Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Return on Assets: 2020-2025

Historic Return on Assets for Kymera Therapeutics (KYMR) over the last 5 years, with Sep 2025 value amounting to -0.30%.

  • Kymera Therapeutics' Return on Assets fell 8.00% to -0.30% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.30%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of -0.34% for FY2024, which is 6.00% down from last year.
  • As of Q3 2025, Kymera Therapeutics' Return on Assets stood at -0.30%, which was up 2.22% from -0.30% recorded in Q2 2025.
  • In the past 5 years, Kymera Therapeutics' Return on Assets ranged from a high of -0.10% in Q1 2021 and a low of -0.33% during Q3 2023.
  • Moreover, its 3-year median value for Return on Assets was -0.29% (2023), whereas its average is -0.28%.
  • Per our database at Business Quant, Kymera Therapeutics' Return on Assets fell by 13bps in 2022 and then rose by 11bps in 2024.
  • Quarterly analysis of 5 years shows Kymera Therapeutics' Return on Assets stood at -0.16% in 2021, then decreased by 10bps to -0.26% in 2022, then dropped by 3bps to -0.29% in 2023, then rose by 3bps to -0.26% in 2024, then fell by 8bps to -0.30% in 2025.
  • Its last three reported values are -0.30% in Q3 2025, -0.30% for Q2 2025, and -0.29% during Q1 2025.